754P A Phase I/IIa Dose Escalation Study of AFM24 in Patients with Epidermal Growth Factor Receptor-Expressing (EGFR) Solid Tumors: Results from Phase I
Annals of Oncology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2022)